These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 37149244)
1. Risks of Topical Carbonic Anhydrase Inhibitors in Glaucoma Patients With Chronic Kidney Disease: A Nationwide Population-Based Study. Wang YC; Ling XC; Tsai WH; Liu JS; Kuo KL Am J Ophthalmol; 2023 Sep; 253():49-55. PubMed ID: 37149244 [TBL] [Abstract][Full Text] [Related]
2. Switching from systemic to the topical carbonic anhydrase inhibitor dorzolamide: effect on the quality of life of glaucoma patients with drug-related side effects. Nesher R; Ticho U Isr Med Assoc J; 2003 Apr; 5(4):260-3. PubMed ID: 14509130 [TBL] [Abstract][Full Text] [Related]
3. Metabolic acidosis and anaemia associated with dorzolamide in a patient with impaired renal function. Hoffmanová I; Sánchez D Br J Clin Pharmacol; 2018 Apr; 84(4):796-799. PubMed ID: 29333622 [TBL] [Abstract][Full Text] [Related]
4. Metabolic acidosis is associated with increased risk of adverse kidney outcomes and mortality in patients with non-dialysis dependent chronic kidney disease: an observational cohort study. Tangri N; Reaven NL; Funk SE; Ferguson TW; Collister D; Mathur V BMC Nephrol; 2021 May; 22(1):185. PubMed ID: 34011303 [TBL] [Abstract][Full Text] [Related]
5. Effect of spironolactone on the risks of mortality and hospitalization for heart failure in pre-dialysis advanced chronic kidney disease: A nationwide population-based study. Tseng WC; Liu JS; Hung SC; Kuo KL; Chen YH; Tarng DC; Hsu CC Int J Cardiol; 2017 Jul; 238():72-78. PubMed ID: 28363684 [TBL] [Abstract][Full Text] [Related]
6. Changes in glaucoma medication numbers after cataract and glaucoma surgery: A nationwide population-based study. Chen HY; Lin CL; Kao CH Medicine (Baltimore); 2019 Jan; 98(4):e14128. PubMed ID: 30681574 [TBL] [Abstract][Full Text] [Related]
7. Topical carbonic anhydrase inhibitors and glaucoma in 2021: where do we stand? Stoner A; Harris A; Oddone F; Belamkar A; Verticchio Vercellin AC; Shin J; Januleviciene I; Siesky B Br J Ophthalmol; 2022 Oct; 106(10):1332-1337. PubMed ID: 34433550 [TBL] [Abstract][Full Text] [Related]
8. Keratitis in six dogs after topical treatment with carbonic anhydrase inhibitors for glaucoma. Beckwith-Cohen B; Bentley E; Gasper DJ; McLellan GJ; Dubielzig RR J Am Vet Med Assoc; 2015 Dec; 247(12):1419-26. PubMed ID: 26642138 [TBL] [Abstract][Full Text] [Related]
17. Recurrent life-threatening acidosis induced by acetazolamide in a patient with diabetic type IV renal tubular acidosis. Elinav E; Ackerman Z; Gottehrer NP; Heyman SN Ann Emerg Med; 2002 Aug; 40(2):259-60. PubMed ID: 12140510 [No Abstract] [Full Text] [Related]
18. Topical carbonic anhydrase inhibitors and visual function in glaucoma and ocular hypertension. Gugleta K Curr Med Res Opin; 2010 Jun; 26(6):1255-67. PubMed ID: 20350146 [TBL] [Abstract][Full Text] [Related]
19. Nationwide Glaucoma incidence in end stage renal disease patients and kidney transplant recipients. Moon JJ; Kim YW; Oh BL; Han K; Kim DK; Joo KW; Kim YS; Park KH; Lee H; Kim YC; Jeoung JW Sci Rep; 2021 Apr; 11(1):7418. PubMed ID: 33795815 [TBL] [Abstract][Full Text] [Related]
20. Association between normal tension glaucoma and the risk of Alzheimer's disease: a nationwide population-based cohort study in Taiwan. Chen YY; Lai YJ; Yen YF; Shen YC; Wang CY; Liang CY; Lin KH; Fan LW BMJ Open; 2018 Nov; 8(11):e022987. PubMed ID: 30397009 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]